ArticleBiotechnology reports (Amsterdam, Netherlands)2017

Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients.

Mahesh Kudrimoti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.